TAP Spectracef
Executive Summary
NDA for the cephalosporin antibiotic cefditoren pivoxil submitted Dec. 28 for acute exacerbations of chronic bronchitis, sinusitis, pharyngitis and skin structure infections in adults and adolescents. TAP is also conducting pediatric studies of Spectracef and plans to file for pediatric indications in the future